Everest Medicines to Announce Interim Results

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim results for the six months ended June 30, 2025, and provide a business update on August 29, 2025. The Company will hold live conference calls in English and Mandarin on August 29, 2025, Beijing Time.

The English session of the conference call will be held at 8:00 AM on August 29, 2025, Beijing Time (8:00 PM U.S. Eastern Time on August 28, 2025), and the Mandarin session of the conference call will be held at 9:30 AM Beijing Time on the same day (9:30 PM U.S. Eastern Time on August 28, 2025).

The conference calls can be accessed by the following links:

For English Session:

Time: 8:00 AM Beijing Time, Friday, August 29, 2025 (8:00 PM U.S. Eastern Time, Thursday, August 28, 2025)

Pre-Registration Link: https://www.acecamptech.com/eventDetail/60525881

Webcast Link:
https://www.acecamptech.com/meeting_live/70527911/811717?event_id=60525881

Alternatively, participants may dial in to the conference call using below dial-in information:

For Mandarin Session:

Time: 9:30 AM Beijing Time, Friday, August 29, 2025 (9:30 PM U.S. Eastern Time, Thursday, August 28, 2025)

Webcast Link: https://s.comein.cn/encsgfgi

Alternatively, participants may dial into the conference call using below dial-in information:

The replay of English session will be available shortly after the call and can be accessed by visiting the Company's website at http://www.everestmedicines.com.